https://www.fxempire.com/stocks/janx/news
Janux Therapeutics, Inc. Common Stock (JANX) Stock Forecasts & News | FXEmpire
Explore the latest news and expert analysis on Janux Therapeutics, Inc. Common Stock (JANX) stock. Stay informed with in-depth forecasts, and insightful...
common stockjanuxtherapeuticsincjanx
https://finviz.com/news/198168/janux-therapeutics-janx-gets-initiated-with-a-buy-rating-at-truist-financial
Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial
Stock screener for investors and traders, financial visualizations.
https://www.macrotrends.net/stocks/charts/JANX/janux-therapeutics/ebitda
Janux Therapeutics EBITDA 2020-2025 | JANX | MacroTrends
Janux Therapeutics ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
januxtherapeuticsebitda20202025
https://www.insidermonkey.com/blog/is-janux-therapeutics-inc-nasdaqjanx-the-best-up-and-coming-stock-to-buy-according-to-wall-street-analysts-1492970/
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall...
We recently published a list of the 12 Best Up and Coming Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at...
https://app.januxia.com/
Janux
Crea y gestiona tus propios agentes de IA con Janux.
janux
https://finviz.com/quote?t=JANX&ta=1&p=d&ty=si&b=2
JANX - Janux Therapeutics Inc Short Interest
JANX - Janux Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
janxjanuxtherapeuticsincshort
https://www.macrotrends.net/stocks/charts/JANX/janux-therapeutics/gross-profit
Janux Therapeutics Gross Profit 2020-2026 | JANX | MacroTrends
Janux Therapeutics gross profit from 2020 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly...
gross profitjanuxtherapeutics20202026
https://www.macrotrends.net/stocks/charts/JANX/janux-therapeutics/shares-outstanding
Janux Therapeutics Shares Outstanding 2020-2026 | JANX | MacroTrends
Janux Therapeutics shares outstanding from 2020 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders)...
shares outstandingjanuxtherapeutics20202026
https://finviz.com/news/231032/jones-trading-remains-bullish-on-janux-therapeutics-janx-amid-promising-developments-in-prostate-cancer-program
Jones Trading Remains Bullish on Janux Therapeutics (JANX) Amid Promising Developments in Prostate...
Stock screener for investors and traders, financial visualizations.
https://finviz.com/quote?t=JANX&ta=1&p=d&ty=fc&b=2
JANX - Janux Therapeutics Inc Forecast, Target Price
JANX - Janux Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
janxjanuxtherapeuticsincforecast
https://www.finder.com/stock-trading/buy-janux-therapeutics-stock
How to Buy Janux Therapeutics Stock (JANX)
Jun 11, 2021 - We explain how to buy Janux Therapeutics Inc stock, compare the best stock trading platforms and use a detailed analysis to learn about (JANX).
how to buyjanuxtherapeuticsstockjanx
https://www.pharmaceutical-technology.com/data-insights/janx-007-janux-therapeutics-net-present-value/
Risk Adjusted Net Present Value: What is the current valuation of Janux Therapeutics's JANX-007
Jun 13, 2024 - JANX-007 is a fusion protein commercialized by Janux Therapeutics, with a leading Phase I program in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
https://finviz.com/news/87642/jonestrading-remains-bullish-on-janux-therapeutics-janx-with-a-90-price-target
JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
Stock screener for investors and traders, financial visualizations.
https://www.finanznachrichten.de/nachrichten-2025-12/67125267-morning-market-movers-taoping-janux-therapeutics-mongodb-american-bitcoin-corp-see-big-swings-020.htm
Morning Market Movers: Taoping, Janux Therapeutics, MongoDB, American Bitcoin Corp. See Big Swings
CANBERA (dpa-AFX) - At 7:25 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential...
https://www.biospace.com/press-releases/janux-therapeutics-to-host-virtual-r-d-day-on-july-24-2025
Janux Therapeutics to Host Virtual R&D Day on July 24, 2025 - BioSpace
https://finviz.com/news/262874/why-wall-street-sees-big-potential-in-janux-therapeutics-inc-janx
Why Wall Street Sees Big Potential in Janux Therapeutics, Inc. (JANX)
Stock screener for investors and traders, financial visualizations.
wall streetseesbig
https://www.fiercebiotech.com/biotech/januxs-t-cell-engager-makes-waves-again-latest-data-drop-solidifying-best-class-spot-late
Janux's T-cell engager makes waves, again, with new data drop
Dec 3, 2024 - Among patients with heavily pretreated prostate cancer, all 16 patients who received JANX007 achieved a 50% decline in prostate-specific antigens.
t cell engager
https://www.home.saxo/fr-be/markets/stocks/janx-xnas
Janux Therapeutics Inc action | Saxo Bank
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer.
januxtherapeuticsincactionsaxo
https://www.businesswire.com/news/home/20201218005115/en/Janux-Therapeutics-Announces-Collaboration-with-Merck-to-Develop-Novel-Drug-Candidates-for-Immuno-Oncology-using-T-Cell-Engager-TRACTr-Technology
Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for...
Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
collaboration with
https://www.januxrx.com/
Janux Therapeutics | Novel T Cell Immunotherapies
Oct 31, 2025 - Janux is developing novel immunotherapies that selectively modulate T cells to fight cancer and autoimmune diseases without causing systemic safety issues.
novel tjanuxtherapeuticscellimmunotherapies
https://www.home.saxo/da-dk/markets/stocks/janx-xnas
Janux Therapeutics Inc aktie | Saxo
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer.
januxtherapeuticsincaktiesaxo
https://finviz.com/news/46593/janux-therapeutics-inc-janx-among-unknown-billionaire-phill-gross-stock-picks-with-huge-upside-potential
Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross' Stock Picks with Huge...
Stock screener for investors and traders, financial visualizations.
https://www.home.saxo/fr-ch/markets/stocks/janx-xnas
Janux Therapeutics Inc action | Saxo Bank Suisse
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer.
saxo bankjanuxtherapeuticsincaction
https://www.fiercebiotech.com/biotech/janux-pairs-up-merck-for-a-1b-plus-t-cell-engager-deal
Janux pairs up with Merck for $1B-plus T-cell engager deal | Fierce Biotech
https://www.nasdaq.com/market-activity/stocks/janx
Janux Therapeutics, Inc. Common Stock (JANX) Stock Price, Quote, News & History | Nasdaq
Discover real-time Janux Therapeutics, Inc. Common Stock (JANX) stock prices, quotes, historical data, news, and Insights for informed trading and investment...
common stockprice quotenews historyjanuxtherapeutics
https://finviz.com/news/315826/where-is-janux-therapeutics-janx-headed-according-to-analysts
Where is Janux Therapeutics (JANX) Headed According to Analysts?
Stock screener for investors and traders, financial visualizations.
where isaccording tojanuxtherapeuticsjanx
https://finviz.com/quote?t=JANX&ta=1&p=d&ty=oc&b=2
JANX - Janux Therapeutics Inc Options
JANX - Janux Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
janxjanuxtherapeuticsincoptions